X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
IT, banking stocks not in favor 
(Fri, 5 Oct 01:30 pm) 
 
The Indian equity markets continued to trade in the negative territory, albeit in a range bound manner during the post noon trading session. While stocks from the FMCG and auto spaces have managed to find some gains, other sectoral indices are trading weak led by information technology and banking stocks.

The Sensex today is trading lower by about 140 points (down 0.7%), while the NSE-Nifty is trading lower by about 40 points (0.7%). Stocks from the midcap and smallcap spaces are also trading weak with the BSE Mid Cap and BSE Small Cap indices down by about 0.8% and 1.1% respectively. The rupee is trading at 51.71 to the US dollar.

Stocks of pharmaceutical companies are trading weak led by Pfizer, Novartis and Abbott India. As per a leading financial daily, the commerce department is going in a big way to grab US$ 30-40 bn worth of the overseas generics market as patents held by multinational companies set to expire over the next three years. Under its recently launched 'Brand India Pharma' campaign, the commerce department wants to hard-sell Indian generics in difficult but promising markets where the focus will be on credibility, quality, availability and affordability of Indian medicines. Reportedly, India's pharma exports stood at $13 billion in 2011. The country produces 20% of the generic medicines of the world and accounts for about 70% of medicines supplied to poor countries through humanitarian agencies. Recently, the commerce department led two delegations comprising Indian pharma companies like Dr. Reddy's, Lupin, Mylan and Nectar, to Japan and Indonesia under the Brand India Pharma Campaign to explore opportunities there.

Stocks of real estate and construction companies are trading weak led by IVRCL, Gammon India andUnity Infraprojects. After declining sharply in yesterday's trading session, the stock of midcap construction company IVRCL is trading down by about 5% today as well. Declines in the stock are seemingly on the back of reports of the Essel Group selling its 12.27% stake in IVRCL yesterday. It may be recollected that the Essel Group had expressed interest in increasing its stake in IVRCL, after buying into the company about six months ago. In fact, the buzz surrounding the stock of IVRCL was of a possible hostile takeover bid leading it to gain significantly.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "IT, banking stocks not in favor". Click here!

  
 

S&P BSE SENSEX


Apr 26, 2017 (Close)

MARKET STATS